Newsletter | December 8, 2022

12.08.22 -- Biocon Completes Acquisition Of Viatris Biosimilar Business

Featured Editorial
Industry Insights
The Dynamic Regulatory Environment Of Drug-Device Combination Products

This white paper examines the dynamic regulatory environment of drug-device combination products and provides concrete steps to take to navigate regulatory complexities and decrease time-to-market.

COVID-19 Impact To Biological Drug Products Safety

Review currently available literature, our recommended COVID-19 virus detection test methods, and susceptibility of common biological host cells to infection.

Generating A Robust Host Cell Line For A Cell Line Development Platform

Learn how cell performance within the context of the cell line development workflow was confirmed with the successful isolation of stable, high-producing clones from three model monoclonal antibodies.

Liposomal And Nanoparticle Technology At Pfizer Melbourne

Specializing in oncology, anti-infective, and complex formulations, the facility provides end-to-end services from development through to commercial manufacture of sterile dosage forms.

Wearable Injectors: An Alternative To Traditional Intravenous Administration

See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.